Tu1775 SWITCHING INFLIXIMAB TO SUBCUTANEOUS FROM INTRAVENOUS THERAPY (SWIMSUIT) – A PROSPECTIVE, REAL-WORLD, SINGLE CENTRE, PHASE IV INTERVENTIONAL STUDY.
- Resource Type
- Abstract
- Source
- In
Gastroenterology May 2023 164(6) Supplement:S - Subject
- Language
- ISSN
- 0016-5085